Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaxi Yang

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Chemsuschem|April 24, 2024
Switchable Regioselective C-H Activation/Annulation of Acrylamides with Alkynes for the Synthesis of 2-PyridonesChao Chen, Yanni Chen, Zijian Han, et al.
Journal of Medicinal Chemistry|August 5, 2025
Discovery of Highly Potent, Selective, and Liver-Targeted THR-β Agonists for the Treatment of Metabolic Dysfunction-Associated SteatohepatitisJu Liang, Yipei Gu, Liuyu Hu, et al.
Frontiers in Immunology|February 25, 2025
Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancerYuankui Zhu, Yaxi Yang, Linghe Yue, et al.
Angewandte Chemie (International Ed. in English)|June 12, 2022
Discovery of a Potent and Selective Degrader for USP7Yuan Pei, Jingfeng Fu, Yunkai Shi, et al.
Chemical Science|March 29, 2024
Discovery of potent PROTAC degraders of Pin1 for the treatment of acute myeloid leukemiaYunkai Shi, Minmin Liu, Mengna Li, et al.
Journal of Medicinal Chemistry|January 8, 2020
Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases InhibitorsYaxi Yang, Rukang Zhang, Zhaojun Li, et al.
Journal of Medicinal Chemistry|March 11, 2024
Uncovering PROTAC Sensitivity and Efficacy by Multidimensional Proteome Profiling: A Case for STAT3Yuying Suo, Daohai Du, Chao Chen, et al.
European Journal of Medicinal Chemistry|March 29, 2021
Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degradersXiangbo Yang, Zhijia Wang, Yuan Pei, et al.
Journal of Medicinal Chemistry|July 19, 2024
Discovery of a Highly Potent, Selective and Efficacious USP7 Degrader for the Treatment of Acute Lymphoblastic LeukemiaMiaomiao Xu, Jingfeng Fu, Yuan Pei, et al.
Journal of Cancer|March 14, 2022
Highly Potent Immunotoxins Targeting the Membrane-distal N-lobe of GPC3 for Immunotherapy of Hepatocellular CarcinomaJingwen Li, Lanxin Xiang, Qian Wang, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Chemsuschem|April 24, 2024
Switchable Regioselective C-H Activation/Annulation of Acrylamides with Alkynes for the Synthesis of 2-PyridonesChao Chen, Yanni Chen, Zijian Han, et al.
Journal of Medicinal Chemistry|August 5, 2025
Discovery of Highly Potent, Selective, and Liver-Targeted THR-β Agonists for the Treatment of Metabolic Dysfunction-Associated SteatohepatitisJu Liang, Yipei Gu, Liuyu Hu, et al.
Frontiers in Immunology|February 25, 2025
Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancerYuankui Zhu, Yaxi Yang, Linghe Yue, et al.
Angewandte Chemie (International Ed. in English)|June 12, 2022
Discovery of a Potent and Selective Degrader for USP7Yuan Pei, Jingfeng Fu, Yunkai Shi, et al.
Chemical Science|March 29, 2024
Discovery of potent PROTAC degraders of Pin1 for the treatment of acute myeloid leukemiaYunkai Shi, Minmin Liu, Mengna Li, et al.
Journal of Medicinal Chemistry|January 8, 2020
Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases InhibitorsYaxi Yang, Rukang Zhang, Zhaojun Li, et al.
Journal of Medicinal Chemistry|March 11, 2024
Uncovering PROTAC Sensitivity and Efficacy by Multidimensional Proteome Profiling: A Case for STAT3Yuying Suo, Daohai Du, Chao Chen, et al.
European Journal of Medicinal Chemistry|March 29, 2021
Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degradersXiangbo Yang, Zhijia Wang, Yuan Pei, et al.
Journal of Medicinal Chemistry|July 19, 2024
Discovery of a Highly Potent, Selective and Efficacious USP7 Degrader for the Treatment of Acute Lymphoblastic LeukemiaMiaomiao Xu, Jingfeng Fu, Yuan Pei, et al.
Journal of Cancer|March 14, 2022
Highly Potent Immunotoxins Targeting the Membrane-distal N-lobe of GPC3 for Immunotherapy of Hepatocellular CarcinomaJingwen Li, Lanxin Xiang, Qian Wang, et al.
Pageof 7